Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
株式のランク #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
株価
$44.60
時価総額
$108.62B
変化(1日)
-1.63%
変化(1年)
-21.62%
FR
取引 Sanofi (SNY)

カテゴリー

Sanofi(SNY)の営業利益率
March 2026 時点の営業利益率 TTM: 25.39%
Sanofi の最新の財務報告と株価によると、現在の営業利益率(TTM)は 25.39% です。2024 年末時点では 21.47% でした。
Sanofi の営業利益率の履歴(2000 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) 25.39% -22.28%
2025 32.67% 52.17%
2024 21.47% 25.48%
2023 17.11% -53.76%
2022 37.00% 78.40%
2021 20.74% -4.11%
2020 21.63% 5.77%
2019 20.45% -41.30%
2018 34.84% 5.10%
2017 33.15% -6.80%
2016 35.57% -2.44%
2015 36.46% -7.58%
2014 39.45% -5.12%
2013 41.58% -4.79%
2012 43.67% 167.09%
2011 16.35% -12.14%
2010 18.61% -10.10%
2009 20.70% -38.90%
2008 33.88% 67.39%
2007 20.24% 4.17%
2006 19.43% -25.64%
2005 26.13% -1,593.14%
2004 -1.75% -104.58%
2003 38.21% 8.89%
2002 35.09% 8.10%
2001 32.46% 22.72%
2000 26.45% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
45.56% -98.21%
US
23.28% -99.08%
GB
27.17% -98.93%
US
26.72% -98.95%
US
31.24% -98.77%
CH
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。